Garheng Kong

Garheng Kong is a Raleigh-based investor associated with HealthQuest Capital, writing $250K-plus checks at seed and Series A into medical devices and digital health. The HealthQuest affiliation is the strongest signal: it is a healthcare-specialist growth fund with deep operating relationships across devices, services, and tech-enabled care, which translates to high diligence standards on clinical evidence, regulatory pathway, and reimbursement strategy. The Raleigh base places him in the Research Triangle ecosystem with strong ties to Duke, UNC, and the broader Mid-Atlantic device and biotech corridor. AI is not flagged as a focus, so the framing is on practical device and care-delivery economics rather than algorithm-led pitches. There is no LinkedIn listed, so the entry path runs through HealthQuest Capital directly or via warm introductions from mutual healthcare investor or operator connections. The check size and stage range place him in the bracket where he can co-lead small rounds rather than only participating as a signal investor. Founders most likely to fit are seed and Series A device companies with clear FDA pathways, digital health teams with credible reimbursement plans, and tech-enabled care models with strong early operating metrics. Pre-product biotech, consumer wellness, and pure software without a healthcare wedge are weaker matches. The entry path is via HealthQuest Capital directly or a warm introduction from a mutual healthcare growth or specialist investor, with the pitch framed around clinical evidence, reimbursement, and the specific reason a healthcare-specialist angel materially accelerates downstream rounds.